Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Common Equity (2018 - 2026)

Health Catalyst filings provide 9 years of Common Equity readings, the most recent being $138.1 million for Q1 2026.

  • On a quarterly basis, Common Equity fell 63.34% to $138.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $138.1 million, a 63.34% decrease, with the full-year FY2025 number at $245.8 million, down 32.7% from a year prior.
  • Common Equity hit $138.1 million in Q1 2026 for Health Catalyst, down from $245.8 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $480.9 million in Q1 2022 to a low of $138.1 million in Q1 2026.
  • Median Common Equity over the past 5 years was $366.9 million (2023), compared with a mean of $366.7 million.
  • Biggest five-year swings in Common Equity: soared 78.89% in 2022 and later plummeted 63.34% in 2026.
  • Health Catalyst's Common Equity stood at $425.0 million in 2022, then decreased by 13.67% to $366.9 million in 2023, then dropped by 0.47% to $365.2 million in 2024, then plummeted by 32.7% to $245.8 million in 2025, then plummeted by 43.79% to $138.1 million in 2026.
  • The last three reported values for Common Equity were $138.1 million (Q1 2026), $245.8 million (Q4 2025), and $331.9 million (Q3 2025) per Business Quant data.